Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases

This study tests a new type of immune cell therapy — called gamma delta T cells — combined with low-dose radiation, for people with advanced lung cancer or solid tumors that have spread to the bones. Researchers are checking whether this treatment is safe. **You may be eligible if...** - You are 18 or older and weigh at least 50 kg - You have advanced non-small cell lung cancer (NSCLC) or a solid tumor with bone metastases - Your cancer has progressed after standard treatments including platinum-based chemotherapy and immunotherapy - You are in fairly good physical condition (ECOG score 0–1) **You may NOT be eligible if...** - You have active autoimmune disease or are on immune-suppressing drugs - You have uncontrolled brain metastases - You have had prior treatment with gamma delta T cell therapy - You have serious heart, liver, or kidney problems - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.